Reference
Fosbol MO, et al. 223Ra therapy of advanced metastatic castration-Resistant prostate cancer: Quantitative assessment of skeletal tumor burden for prognostication of clinical outcome and hematologic toxicity. Journal of Nuclear Medicine 59: 596-602, No. 4, Apr 2018. Available from: URL: http://doi.org/10.2967/jnumed.117.195677 - Denmark
Rights and permissions
About this article
Cite this article
Radium 223 chloride. Reactions Weekly 1702, 219 (2018). https://doi.org/10.1007/s40278-018-46329-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-46329-3